Back

Risk stratification in heart-failure-patients with EF <35% during waiting with usage of the WCD in 203 patients - Recovery depending on age and baseline ejection fraction -

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic heart failure – Pathophysiology and mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Lutz Lichtenberg

St. Vinzenz-Hospital, Cologne (Germany)

18 More presentations in this session

Presentation thumbnail
The decreasing limb of frank and starlings law of the heart is associated with an increase in left ventricular end-diastolic volume
Associate Professor P. Lav Madsen (Herlev, DK)
Abstract
Presentation thumbnail
Prevalence, causes and consequences of interatrial dyssynchrony in cardiac amyloidosis
Doctor L. Nahory (Creteil, FR)
Abstract Slides
Presentation thumbnail
Prognostic significance of myocardial DPP-4 expression level in patients with heart failure
Doctor M. Hirose (Chiba, JP)
Abstract
Presentation thumbnail
Relationship between malnutrition and sympathetic overactivation in patients with chronic heart failure
Doctor R. Ushijima (Toyama, JP)
Abstract
Presentation thumbnail
Lack of SIRT5 accelerates the development of heart failure following transverse aortic constriction
Professor H. Bugger (Graz, AT)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Chronic heart failure – Pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources